# Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

> **NCT05921318** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Hematologic Malignancy
- Stem Cell Transplant Complications

## Interventions

- **COMBINATION_PRODUCT:** Beijing protocol

## Key facts

- **NCT ID:** NCT05921318
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2024-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05921318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05921318, "Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05921318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*